L & S ADVISORS INC – Alnylam Pharmaceuticals, Inc. Transaction History
L & S ADVISORS INC portfolio value:
$0
portfolio value
L & S ADVISORS INC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -9.33K shares | -1.36M | $200.16 | 0 |
| Q2 2022 | share | Increase | 0.00% | 9.33K shares | 1.36M | $145.85 | 9.33K |
| Q3 2020 | share | Decrease | -100.00% | -4.75K shares | -704K | $145.6 | 0 |
| Q2 2020 | share | Increase | +102.90% | 2.40K shares | 449K | $148.11 | 4.75K |
| Q1 2020 | share | Decrease | -55.35% | -2.90K shares | -349K | $108.85 | 2.34K |
| Q4 2019 | share | Increase | 0.00% | 5.24K shares | 604K | $115.17 | 5.24K |